Twist Bioscience Corp — Director's Dealing 2021

Mar 5, 2021

SEC Form 4/A — Form 4/A

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2020-02-04

Reporting Person: CRANDELL KEITH (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-04	Director Stock Option (right to buy)	$26.20	A	11297	Acquired	2030-02-03	Common Stock (11297)	Direct

Footnotes

F1: The Form 4 originally filed on February 7,2020 incorrectly reported 5,648 options.

F2: 100% of the shares subject to the option will vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date.